Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?

Archives of Pediatrics and Adolescent Medicine

Volumn 153, Issue 2, 1999, Pages 119-125

  Shafer, Mary Ann B ^a,b   Pantell, Robert H ^a,b   Schachter, Julius ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHLAMYDIA TRACHOMATIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; LIGASE CHAIN REACTION; MASS SCREENING; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; URINALYSIS;

EID: 0032914938     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.153.2.119     Document Type: Article

References (39)

1. Alan Guttmacher Institute. Sex and America's Teenagers. New York, NY: Alan Guttmacher Institute; 1994.
2. US Department of Health and Human Services, Public Health Service. Sexually Transmitted Disease Surveillance, 1995. Atlanta, Ga; Centers for Disease Control and Prevention; 1996.
3. Kann L, Warren CW, Harris WA, et al. Youth risk behavior surveillance-United States, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:1-83.
4. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep. 1993;42(No. RR-12).
5. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria. Va: International Medical Publishing; 1996.
6. US Public Health Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives 1990. Washington, DC: Government Printing Office; 1990.
7. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC; National Academy of Sciences; 1997.
8. Elster AB, Kuznets NJ, eds. AMA Guidelines tor Adolescent Preventive Services (GAPS). Baltimore, Md: Williams & Wilkins; 1994.
9. Green M, ed. Bright Futures: Guidelines tor Health Supervision of Infants, Children, and Adolescents. Arlington, Va: National Center for Education in Maternal and Child Health; 1994.
10. Shingleton HM, Patrick RL, Johnston WW, et al. The current status of the Papanicolaou smear. CA Cancer J Clin. 1995;45:305-320.
11. Committee on Professional Standards. Guidelines for Women's Health Care. Washington, DC: American College of Obstetricians and Gynecologists: 1995.
12. Chernesky MA, Jang D, Lee HH, et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first void urine by ligase chain reaction. J Clin Microbiol. 1994;32:2683-2685.
13. Biro FM, Reising SF, Doughman JA, et al. A comparison of diagnostic methods in adolescent girls with and without symptoms of Chlamydia urogenital infection. Pediatrics. 1994;93:476.
14. Schachter J, Moncada J, Whidden R, et al. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Intect Dis. 1995;172:1411-1414.
15. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia Irachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet. 1995;345:213-216.
16. Chernesky MA, Lee H, Schachter J, et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in ligase chain reaction assay. J Infect Dis. 1994;170:1308-1311.
17. Smith KR, Ching S, Lee HH, et al. Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol. 1995;33:455-457.
18. Jaschek G, Gaydos CA, Welsh LE, et al. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay J Clin Microbiol. 1993;31:1209-1212.
19. Perkins CI, Morris CR, Wright WE, eds. Cancer Incidence and Mortality in California by Race/Ethnicity. 1988-1993. Sacramento. Calif Cancer Registry: 1996.
20. Parker SL, long T, Bolden S, et al. Cancer statistics, CA Cancer J Clin 1996;65: 5-27.
21. Frye CA, Weisberg RA. Increasing the incidence of routine pelvic examinations: behavioral medicine;s contribution. Women Health, 1994;21:33-55.
22. Rainey DY, Parsons LH, Kenney PG, Krowchuk DP. Compliance with return appointments for reproductive health care among adolescent Norplant users. J Adolesc Health Care. 1995;16:385-388.
23. Ching S, Lee H, Hook EW, et al. Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol. 1995;13:3111-3114.
24. Stamm WE, Guinan MC, Johnson C, et al. Effect of treatment regimens for N gonorrhoeae on simultaneous infection with C trachomatis. N Engl J Med. 1984;310:545-549.
25. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national chlamydia control strategy. Sex Transm Dis. 1997;24: 131-141.
26. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometriosis among women with cervicitis. Am J Obstet Gynecol. 1985;152:280-286.
27. Sweet RL. Diagnosis and treatment of acute salpingitis. J Reprod Med. 1977; 19:21-30.
28. Eschenbach DA, Holmes KK. Acute pelvic inflammatory disease: current concepts of pathogenesis, etiology and managements. Clin Obstet Gynecol. 1975; 18:35-36.
29. Washington AE, Browner WS, Korenbrot CC. Cost-effectiveness of combined treatment for endocervical gonorrhea. JAMA. 1987;257:2056-2060.
30. Sweet RI. Microbial etiology of pelvic inflammatory disease. In: Landers DV, Sweet RL, eds. Pelvic Inflammatory Disease. New York, NY; Springer; 1997:30-59.
31. Schachter J, Shafer MA, Young M, Ott M. Routine pelvic examinations in asymptomatic young women. N Engl J Med 1996;335:1846-1847.
32. Washington AE, Katz P. Cost and payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000, JAMA. 1991;266: 2565-2569.
33. Millstein SG, Adler NE, Irwin CE. Sources of anxiety about pelvic examinations among adolescent females. J Adolesc Health Care. 1984;5:105-111.
34. Raffle AE, Alden B, Mackenzie EFD. Detection rates for abnormal cervical smears: what are we screening for? Lancet. 1995;345:1469-1473.
35. Beatty ME, Lewis J. Adolescent contraceptive counseling and gynecology: a deficiency in pediatric office-based care. Conn Med. 1994;58:71-78.
36. Ellen JM, McCright J, Garrett KA, Bolan G, Millstein SG. Prevalence of asymptomatic STD screening among African American adolescents. Presented at: International Congress of STDs; October 21, 1997; Seville, Spain.
37. Sadeghi SB, Hsieh EW, Gun SW. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Am J Obstet Gynecol. 1984;148: 726-729.
38. Blake DR, Joffe A, Duggan A, et al. Sexually transmitted disease evaluation in young women; can it be done without a speculum [abstract]? J Adolesc Health, 1997;20:126.
39. Hook EW, Smith K, Mullen C, et al. Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol. 1997;35:2133-2135.